Search Results - Axel Ruefer

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insu... by Caroline Arber, Gabriela Baerlocher, Yves Chalandon, Michael Daskalakis, Michel Duchosal, Martin Fehr, Sabine Gerull, Tayfun Güngör, Gayathri Nair, Thomas Pabst, Jakob R. Passweg, Barbara Piccolruaz, Christoph Renner, Axel Ruefer, Dominik Schneidawind, Georg Stüssi, Sacha Zeerleder, Jörg P. Halter

    Published in Swiss Medical Weekly (2024-10-01)
    Get full text
    Article


  2. 2

    The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative... by Beatrice Drexler, Jakob R. Passweg, Alexandar Tzankov, Martin Bigler, Alexandre PA Theocharides, Nathan Cantoni, Peter Keller, Georg Stussi, Axel Ruefer, Rudolf Benz, Geneviève Favre, Pontus Lundberg, Ronny Nienhold, Andrea Fuhrer, Christine Biaggi, Markus G. Manz, Mario Bargetzi, Simon Mendez-Ferrer, Radek C. Skoda

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  3. 3

    S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY by Elena Crisà, María Díez Campelo, Ulrich Germing, Elvira Mora Castera, Francisca Hernandez Mohedo, Kündgen Andrea, Ebeling Freja, Mikko Myllymäki, Martin Jädersten, Eva Hellström Lindberg, Detlef Haase, Isabella Capodanno, Antonella Poloni, Carlo Finelli, Monica Crugnola, Claudio Fozza, Anna Calvisi, Chiara Frairia, Giuseppe Pietrantuono, Marco Cerrano, Rosanna Ciancia, Daniela Barraco, Wolf-Karsten Hofmann, Axel Ruefer, Cécile Bally, Pierre Fenaux, Guillermo Sanz Santillana, Valeria Santini

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: